期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

人乳头瘤病毒疫苗的临床研究进展 被引量：1

Progress of Clinical Trial of Human Papilloma Virus Vaccine
原文传递
导出
摘要 人乳头瘤病毒(HPV)是宫颈癌的主要病因,HPV疫苗在预防宫颈癌的发生方面备受关注。目前研制成功的有HPV16、18二价疫苗和HPV6、11、16、18四价疫苗,随着时间的推移,越来越多的热点问题被进一步分析研究。文章就HPV疫苗预防宫颈癌的临床最新研究动态作一综述。
作者 李丽 玛依努尔·尼牙孜 乔友林
机构地区 新疆医科大学 新疆自治区人民医院 中国医学科学院肿瘤研究所肿瘤流行病学研究室
出处 《中国肿瘤》 CAS 2010年第5期321-325,共5页 China Cancer
关键词 人乳头瘤病毒 疫苗 宫颈癌
分类号 R737.33 [医药卫生—肿瘤]
  • 相关文献

参考文献31

  • 1Madrid-Marina V,Torres-Poveda K, Lopez-Toledo G, et al. Advantages and disadvantages of current prophylactic vaccines against HPV[J]. Arch Med Res, 2009, 40(6):471-477.
  • 2Carter JJ, Koutsky LA, Hughes JP, et al. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection[J]. J Infect Dis, 2000, 181 (6): 1911 - 1919.
  • 3Ho GY, Studentsov Y, Bierman R, et al. Natural history of human papillomavirus type 16 virus-like particle antibodies in young women [J]. Cancer Epidemiol Biomarkers Prey, 2004, 13 (1): 110-116.
  • 4Viscidi RP, Schiffman M,Hildesheim A, et al. Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica [J]. Cancer Epidemiol Biomarkers Prey, 2004, 13(2):324-327.
  • 5Zhou J, Sun XY, Stenzel D J, et al. Expression of vaccine recombinant HPV 16 L1 and L20RF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles [J]. Virology, 1991, 185(1):251-257.
  • 6Hagensee ME, Yaegashi N, Galloway DA, et al. Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins[J]. J Virol, 1993, 67(1):315-322.
  • 7Paavonen J, Jenkins D, Bosch FX, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase Ⅲ double-blind, randomised controlled trial[J]. Lancet, 2007, 369(9580):2161- 2170.
  • 8Paavonen J,Naud P, Salmeron J, et al. Efficacy of human papillomavirus (HPV)- 16/18 AS04-adjuvanted vaccine against cervical infection and precaneer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women [J]. Wheeler CM Lancet, 2009, 374 (9686): 301-314.
  • 9Harper DM,Franco EL, Wheeler C, et al. Efficacy of a bivalent L1 virusqike particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial [J]. Lancet, 2004, 364 (9447): 1757-1765.
  • 10Harper DM, Franco EL, Wheeler CM, et al.Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial [J]. Lancet, 2006, 367(9518):1247-1255.

同被引文献19

  • 1Shi JF, Qiao YL, Smith JS, et al. Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia[J]. Vaccine, 2008, 19(26) : 53 - 9.
  • 2Burchell AN, Winer RL, de Sanjos S, et al. Epidemiology and transmission dynamics of genital HPV infection [ J ]. Vaccine,2006, 24(3) :52- 61.
  • 3Parkin DM, Bray F. The burden of HPV- related cancers[J]. Vaccine, 2006, 31(24) : 11 - 25.
  • 4Walboomers JM, Jacobs MV, Manos MM, et al. Human papillo- mavirus is a necessary cause of invasive cervical cancer worldwide [J].J Pathol, 1999, 189(1):12.
  • 5Chen W , Zhang X , Molijin A , et al. Human papillomavirus type - distribution in cervical in china: The importance of HPV 16 and 18[J]. Cancer Causes Control, 2009, 20(9) : 1 705.
  • 6XG Jia. Reproductive Tract Infection and Reprodueive Health in Chinese Women[J]. China Maternal and Child Health, 1997, 12 (1):49- 51.
  • 7LQ Yah. Epidemiology and Risk factors for lower Reproductive Tract infection in Women living in Lu Liang community of Chengjiang[J]. Modem Preventive Medicine, 1997,24:3.
  • 8LH Wang, GL Zhao, LJ Chen, et al. A prevalence survey of pro- ductive tract infection in married women [ J ]. Chinese Journal of Epidemiology, 2000, 21:464.
  • 9CG Shao. Prevention and Treatment of STD and its Stxategy in China[J]. Chinese Journal of Dermatology, 1993, 26 : 131 - 133.
  • 10H Wang, Y L Qiao. Human papillomavirus type - distribution in condylomata acuminata of China's Mainland: a meta- analysis[J]. International Journal of STD & AIDS, 2008, 19 : 680 - 684.

引证文献1

二级引证文献1

中国肿瘤
2010年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部